Lidocaine topical system 1.8%

DRUG5 trials

Sponsors

Scilex Pharmaceuticals, Inc.

Conditions

Healthy

Phase 1

Comparative Pharmacokinetic Study of Lidocaine Patch 1.8% (ZTlido™) and Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects

CompletedNCT04149938

Scilex Pharmaceuticals, Inc.Healthy

Start: 2016-09-28End: 2016-10-27Updated: 2019-11-04

Pharmacokinetics and Adhesion of Lidocaine Topical System 1.8% Under Conditions of Heat and Exercise

CompletedNCT04150536

Scilex Pharmaceuticals, Inc.Healthy

Start: 2016-01-08End: 2016-01-25Updated: 2024-05-23

Adhesion of Lidocaine Topical System 1.8%

CompletedNCT04312750

Scilex Pharmaceuticals, Inc.Healthy

Start: 2015-12-31End: 2015-12-31Updated: 2020-03-18

Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Generic Lidocaine Patch 5% in Healthy, Adult, Human Subjects

CompletedNCT04319926

Scilex Pharmaceuticals, Inc.Healthy

Start: 2018-09-07End: 2018-09-09Updated: 2024-04-24

Pharmacokinetics and Adhesion of Lidocaine Topical System 1.8% With Water Exposure

CompletedNCT04784728

Scilex Pharmaceuticals, Inc.Healthy

Start: 2019-08-21End: 2019-08-31Updated: 2021-03-05

Related Papers

A Randomized, Crossover, Adhesion Performance and Pharmacokinetic Study of a Lidocaine Topical System Under Conditions of Water Exposure in Healthy Subjects

Journal of Pain Research2021-08-012 citations

Open-Label Adhesion Performance Studies of a New Lidocaine Topical System 1.8% versus Lidocaine Patches 5% and Lidocaine Medicated Plaster 5% in Healthy Subjects

Journal of Pain Research2021-02-017 citations

<p>A Randomized, Open-Label, Bioequivalence Study of Lidocaine Topical System 1.8% and Lidocaine Patch 5% in Healthy Subjects</p>

Journal of Pain Research2020-06-0111 citations

<p>A Randomized, Crossover, Pharmacokinetic and Adhesion Performance Study of a Lidocaine Topical System 1.8% During Physical Activity and Heat Treatment in Healthy Subjects</p>

Journal of Pain Research2020-06-018 citations